Zinc Fingers, TAL Effectors, or Cas9-Based DNA Binding Proteins: What’s Best for Targeting Desired Genome Loci?  Annett Strauβ, Thomas Lahaye  Molecular.

Slides:



Advertisements
Similar presentations
TALENs. Transcription activator-like effectors (TALEs) are produced by plant pathogenic bacteria in the genus Xanthomonas Target host cells via type III.
Advertisements

Breakthrough Technology to Improve the Range and Accuracy of Cas9 Target.
Genome Editing by Matthew Porteus Department of Pediatrics,
Genome editing to breed better plants
Institute of Health and Biomedical Innovation
Pluripotent stem cell based gene therapy for hematological diseases
by Prarthana Mohanraju, Kira S
Expanding the Biologist’s Toolkit with CRISPR-Cas9
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Volume 56, Issue 4, Pages (November 2014)
Xiaoyu Chen, Manuel A.F.V. Gonçalves  iScience 
Dan Ding, Kaiyuan Chen, Yuedan Chen, Hong Li, Kabin Xie 
Rewiring Cas9 to Target New PAM Sequences
Volume 38, Issue 4, Pages (May 2010)
Looking forward to genetically edited fruit crops
Strategy for CRISPR/Cas9-mediated genome editing in ΔEx50 mice
Harnessing CRISPR–Cas systems for bacterial genome editing
Volume 11, Issue 2, Pages (February 2018)
Daan C. Swarts, John van der Oost, Martin Jinek  Molecular Cell 
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Addison V. Wright, James K. Nuñez, Jennifer A. Doudna  Cell 
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Tamas Yelland, Snezana Djordjevic  Structure 
Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology  Joan Ramon Guitart, Jodi L. Johnson,
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Figure 1 Adaptive immune system of bacteria and archaea
Eukaryotic Transcription Activation: Right on Target
Prion-like Domains Program Ewing’s Sarcoma
Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes
Therapeutic editing of hepatocyte genome in vivo
USH2A Gene Editing Using the CRISPR System
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
Volume 164, Issue 1, Pages (January 2016)
RNA-Guided Genome Editing in Plants Using a CRISPR–Cas System
RNAi: Prokaryotes Get in on the Act
Andrew R. Bassett, Charlotte Tibbit, Chris P. Ponting, Ji-Long Liu 
Ryan N. Jackson, Blake Wiedenheft  Molecular Cell 
Volume 28, Issue 6, Pages (December 2007)
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Nicholas D Weber, Daniel Stone, Keith R Jerome  Molecular Therapy 
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Paramutation: From Maize to Mice
Volume 69, Issue 1, Pages e3 (January 2018)
Gene transfer © 2016 Paul Billiet ODWS.
Designer TAL Effectors Induce Disease Susceptibility and Resistance to Xanthomonas oryzae pv. Oryzae in Rice  Ting Li, Sheng Huang, Junhui Zhou, Bing.
Zhao Zhang, Yuelin Zhang, Fei Gao, Shuo Han, Kathryn S
Genome Editing Technologies: Defining a Path to Clinic
Molecular Therapy - Methods & Clinical Development
A CRISPR Approach to Gene Targeting
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Ignazio Maggio, Manuel A.F.V. Gonçalves  Trends in Biotechnology 
Structure of the BRCT Repeats of BRCA1 Bound to a BACH1 Phosphopeptide
DNA Unwinding Is the Primary Determinant of CRISPR-Cas9 Activity
Volume 23, Issue 3, Pages (March 2015)
Gene editing: modifying a gene that was already there
Ciaran M Lee, Thomas J Cradick, Gang Bao  Molecular Therapy 
CRISPR/Cas Systems towards Next-Generation Biosensing
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
CRISPR/Cas9: Transcending the Reality of Genome Editing
Mighty Piwis Defend the Germline against Genome Intruders
Jia Liu, Thomas Gaj, Mark C Wallen, Carlos F Barbas 
The Biology of CRISPR-Cas: Backward and Forward
Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.
Ankita Shrestha, Ahamed Khan, Nrisingha Dey  Molecular Plant 
Molecular Therapy - Methods & Clinical Development
Volume 16, Issue 11, Pages (September 2016)
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
Potent and sequence-specific removal through genome targeting with CRISPR-Cas systems. Potent and sequence-specific removal through genome targeting with.
Presentation transcript:

Zinc Fingers, TAL Effectors, or Cas9-Based DNA Binding Proteins: What’s Best for Targeting Desired Genome Loci?  Annett Strauβ, Thomas Lahaye  Molecular Plant  Volume 6, Issue 5, Pages 1384-1387 (September 2013) DOI: 10.1093/mp/sst075 Copyright © 2013 The Authors. All rights reserved. Terms and Conditions

Figure 1 Programmable DNA Binding Domain Architectures and Derived Designer Nucleases. Zinc finger nucleases (ZFNs) are typically composed of three or four tandem arranged fingers (four-finger ZF is displayed), each binding three base pairs and translationally fused to a FokI nuclease domain. Greatest success has been achieved with zinc fingers consisting of GNN triplets. Interaction of two distinct ZF arrays with their DNA target results in dimerization and activation of FokI. Thus, both ZF arrays contribute additively to target specificity. TAL effector nucleases (TALENs) also typically rely on a fused FokI domain. The TALE DNA binding domain is composed of tandem arranged repeats, each binding one base. The number of repeats is generally highly flexible but typically custom arrays contain about 16–24 repeats (17.5 repeat array is displayed). Recent studies show that ‘unfavored’ base–residue pairings in the N-terminus of the repeat array (5’ of target DNA) have a stronger impact on the interaction with DNA than mispairing in the C-terminus (black triangle; Meckler et al., 2013). RNA-guided endonucleases (RGENs) consist of a protein (Cas9) scaffold with two cleavage domains (RuvC and HNH) and a custom guide RNA (gRNA) that defines specificity. A conserved protospacer adjacent motif (PAM) that limits target flexibility is indicated. Mismatches in the 3’ end of the protospacer target DNA (3’ of guide RNA) have stronger impact on the cleavage activity of RGENs than mismatches in the 5’ end (black triangle; Jinek et al., 2012; Cong et al., 2013; Jiang et al., 2013). Green elements indicate protein or RNA elements that mediate DNA binding. Red and green font indicate invariant and programmable bases, respectively. Numbers above and between the double arrows indicate numbers of bases of the target region and the optimal spacing, respectively. The number of bases that can be programmed without restrictions is given in brackets. Please note that the size of the targeted region and the ideal spacing is to some extent variable and dictated by the given TALEN or ZFN architecture. Molecular Plant 2013 6, 1384-1387DOI: (10.1093/mp/sst075) Copyright © 2013 The Authors. All rights reserved. Terms and Conditions